Mission
myofarm has developed a unique technology and process to analyse iPSC-derived macroscopic human myocard in unprecedented detail.
With this 3D in vitro model of the human heart muscle we support the global transformation to a more efficient and animal free drug development.
Team
Mariyam
Gaysaeva, B.Sc.
Lab & quality management
Andreas
Meyer-Borgstädt, MBA
Business development
& finance
Dr.-Ing. Jan Patrick Pietras, MBA
Engineering
& Life Sciences
Dr. rer. nat.
Hendrik Windel
Software, Hardware & Data-Science
Shameer
Sarwar, B.Sc.
Cloud Architect & Data Science
Advisory
Dr. rer. nat.
George Kensah
HEAD OF EXPERIMENTAL RESEARCH
DEPARTMENT OF THORACIC AND CARDIOVASCULAR SURGERY
UNIVERSITY MEDICAL CENTER GOETTINGEN (UMG)
Dr. med. vet.
Eckhard von Keutz
Previous Senior Vice President and Head of Translational Sciences at Bayer Pharmaceuticals
Das Projekt myofarm wird im Rahmen des EXIST-Programms durch das Bundesministerium für Wirtschaft und Klimaschutz und den Europäischen Sozialfonds gefördert.